Yomogi® Saccharomyces cerevisiae Boulardii

Yomogi - active ingredient Saccharomyces cerevisiae (Boulardii) - strain HANSEN CBS 5926 - also known as CNCM I-745 For the relief and treatment of diarrhoea Helps to reduce and relieve diarrhoea after antibiotic use Helps reduce occurrence of diarrhoea Helps to reduce occurrence and relieve travellers’ diarrhoea May reduce the risk of diarrhoea when travelling Yomogi® is a probiotic that comprises as its active substance 250 mg of lyophilized yeast cells that at batch release contains a minimum of 2.5 billion CFU (colony forming units) of a viable non-pathogenic cells of the yeast strain Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926. Saccharomyces boulardii is indicated for the treatment of diarrhoea, often a symptom of gastrointestinal disorders. Saccharomyces boulardii is able to help and support a healthy microbial environment. Ingredients 1 hard capsule contains: At release – a minimum of 2.5 billion viable cells of Saccharomyces cerevisiae HANSEN CBS 5926 (synonym: Saccharomyces boulardii) in 250 mg lyophilisate. Other ingredients: Lactose, magnesium stearate (Ph.Eur.), gelatin, water, sodium dodecyl sulfate, chlorophyllin-copper complex, titanium dioxide, iron oxide hydrate. Dosage Adults: 1 capsule 1-2 times daily Children: 2-6 years of age, same dosage but the hard capsule is to be opened and contents stirred into food or liquid Travellers’ diarrhoea: 1 capsule 1-2 times daily starting 5 days before departure and continue for the duration of travel. If symptoms persist consult your healthcare practitioner. Yomogi® does not require refrigeration.